EGFR and colorectal carcinoma: Treating CRC cells with an autophagy inhibitor further increased their sensitivity to combined treatment with EGFR and MIs, indicating that autophagy induction is an important mechanism protecting CRC cells against combined iEGFR/MI treatment [257].